ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2130

Bone Microstructure in Patients with Cutaneous Psoriasis and No History of Psoriatic Arthritis Shows Bone Anabolic Changes at a Greater Extent Than in Healthy Controls

David Simon1, Francesca Faustini1, Matthias Englbrecht1, Arnd Kleyer1, Roland Kocijan2, Judith Haschka3, Stephanie Finzel1, Sebastian Kraus3, Axel J. Hueber1, Michael Sticherling4, Georg Schett1 and Jürgen Rech3, 1Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 2Medical Department II, St. Vincent Hospital, Vienna, Austria, 3Internal Medicine 3, Rheumatology and Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 4Department of Dermatology, University of Erlangen-Nuremberg, Erlangen, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Bone, Imaging and psoriasis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Various Imaging Techniques

Session Type: Abstract Submissions (ACR)

Background/Purpose

Psoriasis (PSO) is a frequent disease which affects about 1-2% of the population and can be associated to arthritis (PsA). Skin disease often predates the onset of PsA and the transition from skin to joint pathology has been not yet fully elucidated. PsA bone changes include erosions and new bone formation. Aim of the present study was to investigate whether patients with PSO, without clinical history of synovitis, dactylitis or enthesitis at any time and no fulfillment of CASPAR criteria show early changes of the periarticular bone that are typical of PsA.

Methods

PSO patients and healthy subjects (HS) underwent HR-pQCT (XtremeCT, Scanco Medical, Switzerland) scans of the dominant hand which focused on the metacarpal head and phalangeal base of the MCP joints 2 and 3. Erosions, defined as cortical breaks within the joint and visible in two planes, were assessed by frequency and volume (mm3). Bony spurs, defined as bony projections emerging from the cortical shell and located in the periarticular region were assessed by frequency and maximal height (mm) i.e. the distance between the highest surface of the lesion and the original cortical surface). Patients participated after signing informed consent. The study was conducted upon approval by the local ethic committee and the National Radiation Safety Agency (BfS).

Results Images were acquired from 55 PSO patients (mean age 49.5±11.5 y, 36.4% females) and 47 HS (mean age 45.8±13.0 y, 48.9% females). Mean age and sex distribution were comparable. PSO patients had mean disease duration of 15.2±15.4 y, a mean PASI score of 6.2±8.0, while the most prevalent subtype was psoriasis vulgaris (73%). Nail psoriasis was present in 51 % and scalp involvement in 29%. Erosions were identified in PSO and HS (27 vs 18). The most frequent location of the erosions was the radial aspect of the metacarpal head 2 in both groups. The volume of the erosion was not significantly different between the groups. An average number of 6 bony spurs was found in the PSO patients while this accounted for 3 in the HS (total number 306 vs 138). A similar trend of distribution of bony spurs was found in both groups with the majority of them locating in the metacarpal head 2 (palmar and dorsal aspect). PSO patients showed larger bony spurs compared to the HS in each region of interest. For the metacarpal head 2 the mean size accounted for 1.7±0.8 vs. 1.2±0.5 mm respectively, p=0.001; metacarpal head 3: 1.2±0.6 and 0.8±0.3 mm, p=0.001. In the phalangeal base 2 the PSO patients showed a mean size of 1.3±0.7 mm, and the HS of 0.7±0.3 mm, p<0.001. In the phalangeal base 3 mean values accounted for 1.2±0.7 mm and 0.8±0.2 respectively, p=0.003.

Conclusion

Analysis of the bone microstructure indicates that patients with PSO without PsA show more pronounced anabolic changes than healthy subjects. Periarticular new bone formation could be an early expression of altered bone remodeling previous to the onset of PsA.


Disclosure:

D. Simon,
None;

F. Faustini,
None;

M. Englbrecht,
None;

A. Kleyer,
None;

R. Kocijan,
None;

J. Haschka,
None;

S. Finzel,
None;

S. Kraus,
None;

A. J. Hueber,
None;

M. Sticherling,
None;

G. Schett,
None;

J. Rech,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-microstructure-in-patients-with-cutaneous-psoriasis-and-no-history-of-psoriatic-arthritis-shows-bone-anabolic-changes-at-a-greater-extent-than-in-healthy-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology